Global Molecular Diagnosis Market Analysis By Industry Growth, Size, Share, Demand, Trends and Research Report

SDKI Inc. published a new research report on "Global Molecular Diagnosis Market-Forecast 2022-2030". The report provides a complete assessment of the market and its growth prospects, along with new business opportunities in the industry. It also includes market size and annual growth during the 2022-2030 forecast period.

Report sample URL
https://www.sdki.jp/sample-request-59127

The molecular diagnostics market is estimated to reach US $ 17.51 ​​billion by 2030 from a market value of US $ 9.89 billion in 2022 and is expected to grow at a CAGR of 8.5% during the 2022-2030 forecast period.

Molecular diagnostics are used to investigate biological markers involved in a wide range of human diseases. It is a technology to be done. Molecular diagnostic testing is a fundamental part of a successful medical system. Molecular diagnostic tests provide important information to help healthcare patients and healthcare providers make accurate medical decisions to get better results for their medical procedures. This technique often informs each stage of care and provides quantitative measurements for successful health management. Molecular diagnostic tools enhance clinical settings, provide a sensitive and rapid approach for identification, and monitor a variety of infections, including cancer types and other chronic diseases.

Therefore, the increased incidence of infectious diseases and cancer due to the growing elderly population, and the increased awareness and acceptance of personalized medicine and companion diagnostics are key factors driving the growth of the molecular diagnostics market during the forecast period. According to the International Agency for Research on Cancer (IARC), in 2018, approximately 17 million new cancer cases and 9.5 million cancer deaths were registered worldwide. In addition, the global burden of cancer is expected to increase to approximately 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. This is expected to accelerate the demand for molecular diagnostics. Therefore, it contributes to the growth of the global molecular diagnostics market.

However, a complex regulatory framework that delays the approval of new molecular diagnostic tests could curb the growth of the molecular diagnostic market during the 2022-2030 forecast period.

Sample URL of the report
https://www.sdki.jp/sample-request-59127

Molecular diagnostic market segment

The molecular diagnostics market is by product and service (reagents / kits, equipment, services and software), by technology (polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS). , DNA microarray, etc.)), by application (infectious disease, oncology, genetic testing, etc.), by end user (hospital / academic laboratory, reference laboratory, etc.), and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional Overview of Molecular Diagnosis Market

In addition, the report covers all regions of the world, divided into North America, Europe, Asia Pacific, Latin America, Middle East / Africa and more. North America is the world's leading region in terms of market share. This is due to the increased prevalence of cancer and infectious diseases, the existence of well-developed medical infrastructure, and the rapid increase in clinical laboratories throughout the region. Meanwhile, the Asia Pacific molecular diagnostics market is expected to witness the highest growth rates during the forecast period (2022-2030). Increasing medical costs on a larger population basis and increasing aging populations in countries such as China and India are key factors driving the growth of the molecular diagnostics market in the region.

For more detailed analysis, each region is further divided into countries:
Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Singapore, and other Asia Pacific)
North America (US and Canada)
Middle East and Africa (Israel, GCC [Saudi Arabia, United Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa)
Latin America (Brazil, Mexico, Argentina, and other Latin America)
Europe (UK, Germany, France, Italy, Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe)

Key Players in the Molecular Diagnostic Market

The key players in the molecular diagnostic market include Abbott Laboratories, Becton, Dickinson and Company, Agilent Technologies, Inc., Biomérieux Sa, Danaher Corporation, DiaSorin, Grifols, SA, Hologic, Inc. , Illumina, Inc., Thermo Fisher Scientific, Inc. and more. The study includes a detailed competitive analysis of these major companies in the molecular diagnostics market, corporate profiles, recent developments, and key market strategies.

Details of the research report
https://www.sdki.jp/press-details/global-molecular-diagnostic-market/209

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.